Cirrhosis of the Liver
📧 Sign up to get email alerts when something new happens for Cirrhosis of the Liver.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Primary Prevention Hepatocellular Carcinoma by Metformin [Phase 3]
Phase 3 trial evaluating metformin for primary prevention of hepatocellular carcinoma in people with chronic liver disease, including chroni…
-
CLINICAL_TRIALS withdrawal · 2016-12-15Clinical Trial Update: Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP) [Phase 3]
A Phase 3 trial evaluating adjunctive Vivomixx in patients with cirrhosis and spontaneous bacterial peritonitis has been withdrawn.
-
FDA approval · 2016-10-07FDA Approved: FUROSEMIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
FDA approved a supplemental NDA for furosemide submitted by Marlex Pharmaceuticals, Inc.
-
FDA approval · 2016-09-19FDA Approved: SPIRONOLACTONE — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare, Inc.'s original application for spironolactone (generic), authorizing its use as a potassium-sparing diureti…
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS. [NA]
A completed clinical trial evaluating the immunological effects and metabolic tolerance of lipid infusion in patients with cirrhosis, includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function [Phase 2]
Phase 2 clinical trial update on using the ALFApump System to treat ascites in cirrhosis and its effects on renal and circulatory function.
-
FDA approval · 2016-06-30FDA Approved: ETHACRYNIC ACID — Original Application (Edenbridge Pharmaceuticals LLC.)
The FDA approved Edenbridge Pharmaceuticals' original application for Ethacrynic acid, a loop diuretic used to treat edema associated with h…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Influence of Probiotics on Infections in Cirrhosis [NA]
Completed clinical trial evaluating the effect of probiotic therapy on infections in cirrhosis of the liver.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients [Phase 4]
Phase 4 trial assessing sofosbuvir/simeprevir plus a flat dose of ribavirin in genotype 1 elderly patients with liver cirrhosis; the study i…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot Study
A pilot study evaluating the use of cardiopulmonary exercise testing in patients with cirrhosis (end-stage liver disease) to assess function…
-
CLINICAL_TRIALS research · 2013-10-30Clinical Trial Update: Dynamic Preload Parameters During Liver Transplantation
Clinical trial exploring dynamic preload parameters during liver transplantation in patients with cirrhosis of the liver.
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis [Phase 2]
A Phase II double-blind, randomized trial evaluating Vitalliver in patients with decompensated cirrhosis has completed, assessing efficacy a…
-
CLINICAL_TRIALS research · 2013-05-15Clinical Trial Update: Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites [Phase 3]
A Phase 3 clinical trial evaluating autologous mesenchymal stem cell transplantation for cirrhosis with refractory ascites; current status i…
-
FDA approval · 2011-11-28FDA Approved: SPIRONOLACTONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for spironolactone filed by Amneal Pharmaceuticals LLC, a generic product. The approval confirms cha…
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed [NA]
The trial evaluated the efficacy and safety of nasogastric tube use in patients with upper gastrointestinal hemorrhage, including those with…
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents
This entry reports a clinical trial evaluating novel MR contrast agents for assessing cirrhosis and malignant hepatic lesions, including hep…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) [Phase 3]
This document provides a Phase 3 trial update on pegylated interferon alfa-2b in patients with hepatitis C-related cirrhosis and high liver …
-
FDA approval · 2010-10-18FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.
-
FDA approval · 2009-10-16FDA Approved: CHLOROTHIAZIDE — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's original abbreviated new drug application for chlorothiazide sodium, a thiazide diuretic. The product…
-
FDA approval · 2009-05-04FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers [Phase 1]
Phase 1 trial update on NRL972 shows pharmacokinetic clearance in patients with cirrhosis and in healthy volunteers.
-
FDA approval · 2009-02-06FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for furosemide submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2009-01-12Clinical Trial Update: Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites [Phase 2]
Sanofi conducted a Phase 2 dose-ranging trial of satavaptan in hyponatraemic patients with cirrhotic ascites; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2006-07-11Clinical Trial Update: Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis [Phase 1]
A Phase 1 clinical trial of L-NMMA in patients with cirrhosis of the liver has completed.